You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

XRT

Showing 1 - 25 of 257
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HER2-positive Breast Cancer, LMD Trial (Tucatinib 150 MG, Trastuzumab, Capecitabine)

Not yet recruiting
  • HER2-positive Breast Cancer
  • LMD
  • Tucatinib 150 MG
  • +3 more
  • (no location specified)
Aug 24, 2023

Breast Cancer, Breast Cancer Female, Breast Cancer Stage II Trial in Boston (Accelerated Proton Beam Radiation Therapy (PBT),

Not yet recruiting
  • Breast Cancer
  • +4 more
  • Accelerated Proton Beam Radiation Therapy (PBT)
  • Accelerated Photon Radiation Therapy (XRT)
  • Boston, Massachusetts
    Massachusetts General Hospital Cancer Center
Jun 12, 2023

Esophageal Cancer Trial in Houston (Proton Beam Therapy (PBT), Intensity Modulated Radiation Therapy (IMRT), Questionnaires)

Active, not recruiting
  • Esophageal Cancer
  • Proton Beam Therapy (PBT)
  • +2 more
  • Houston, Texas
    MD Anderson Cancer Center
Oct 11, 2022

Malignant Glioma, Glioblastoma, Gliosarcoma Trial in Durham (Bevacizumab, Temozolomide, Radiation Therapy (XRT))

Completed
Has Results
  • Malignant Glioma
  • +2 more
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke
Mar 29, 2022

Spinal Tumor Trial in Houston (radiation, procedure, behavioral)

Active, not recruiting
  • Spinal Tumor
  • Spinal SBRT (Standard Dose)
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 11, 2022

Lung Cancer, Nonsmall Cell, Lung Cancer Stage III Trial (combination product, drug, procedure, radiation)

Not yet recruiting
  • Lung Cancer, Nonsmall Cell
  • Lung Cancer Stage III
  • Nivolumab and Chemotherapy
  • +3 more
  • (no location specified)
Aug 15, 2023

Recurrent Thyroid Cancer Trial in Baltimore (Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive

Recruiting
  • Recurrent Thyroid Cancer
  • Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)
  • Baltimore, Maryland
    The Johns Hopkins SKCCC
May 25, 2022

Lymphoma Trial in Houston (Radiation Therapy, Dexamethasone, Etoposide phosphate)

Recruiting
  • Lymphoma
  • Radiation Therapy
  • +5 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Dec 9, 2022

Sarcoma Trial in Boston (Bevacizumab, Doxorubicin, Radiation Therapy)

Active, not recruiting
  • Sarcoma
  • Boston, Massachusetts
    Massachusetts General Hospital
Apr 6, 2022

Malignant Tumors of Eye Brain and Other Parts of CNS Trial in Houston (Spine Radiosurgery, Questionnaires)

Recruiting
  • Malignant Neoplasms of Eye Brain and Other Parts of Central Nervous System
  • Spine Radiosurgery
  • Questionnaires
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

HPV-positive Oropharyngeal Squamous Cell Carcinoma Trial in New York (procedure, radiation, drug)

Recruiting
  • HPV-positive Oropharyngeal Squamous Cell Carcinoma
  • Robotic surgery
  • +2 more
  • New York, New York
    Mount Sinai Health System
Oct 26, 2022

Glioblastoma Multiforme Trial in Australia, Austria, Netherlands (4-L-[131I]iodo-phenylalanine (131I-IPA))

Active, not recruiting
  • Glioblastoma Multiforme
  • 4-L-[131I]iodo-phenylalanine (131I-IPA)
  • Gateshead, New South Wales, Australia
  • +4 more
Nov 25, 2021

Pancreatic Ductal Adenocarcinoma Trial in United States (NALIRIFOX, AD-XRT and Capecitabine)

Recruiting
  • Pancreatic Ductal Adenocarcinoma
  • Basking Ridge, New Jersey
  • +6 more
May 15, 2023

Prostate Cancer Trial in United States (GnRH, Bicalutamide, Salvage radiation)

Active, not recruiting
  • Prostate Cancer
  • San Diego, California
  • +7 more
Mar 7, 2022

Refractory Non-Hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Duarte, Hackensack, Houston (SIRPant-M, External-beam

Not yet recruiting
  • Refractory Non-Hodgkin Lymphoma
  • Relapsed Non-Hodgkin Lymphoma
  • SIRPant-M
  • External-beam radiotherapy (XRT)
  • Duarte, California
  • +2 more
Jul 21, 2023

Xerostomia Following Radiotherapy Trial in Madison (Autologous bone-marrow derived, interferon gamma stimulated mesenchymal

Recruiting
  • Xerostomia Following Radiotherapy
  • Autologous bone-marrow derived, interferon gamma stimulated mesenchymal stromal cells
  • Madison, Wisconsin
    University of Wisconsin
Mar 21, 2022

Brain Cancer Trial in Houston (IMPT, IMRT, Cognitive Tests)

Completed
  • Brain Cancer
  • IMPT
  • +3 more
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 14, 2021

Bone Metastases Trial in Gilbert, Voorhees, Houston (Hypofractionated Radiation Treatment, One Radiation Treatment,

Completed
Has Results
  • Bone Metastases
  • Hypofractionated Radiation Treatment
  • +2 more
  • Gilbert, Arizona
  • +2 more
Oct 11, 2021

Prostate Cancer, Oligometastatic Disease Trial in United States (Prostate radiation (XRT), Systemic Therapy, Stereotactic

Recruiting
  • Prostate Cancer
  • Oligometastatic Disease
  • Prostate radiation (XRT)
  • +2 more
  • Baltimore, Maryland
  • +4 more
Oct 10, 2022

Acetabular Fracture, Heterotopic Ossification Trial in Baltimore (External Beam Radiation (XRT), Debridement)

Enrolling by invitation
  • Acetabular Fracture
  • Heterotopic Ossification
  • External Beam Radiation (XRT)
  • Debridement
  • Baltimore, Maryland
    University of Maryland, Shock Trauma Center
Feb 9, 2022

Lung Cancer, NSCLC Trial in Houston (MPDL3280A, Carboplatin, Paclitaxel)

Active, not recruiting
  • Lung Cancer
  • Non-Small Cell Lung Cancer
  • Houston, Texas
    MD Anderson Cancer Center
Apr 28, 2022

Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • Oxaliplatin; Capecitabine
  • Oxaliplatin; Capecitabine; concurrent radiotherapy
  • Shijiazhuang, Hebei, China
    Department of General Surgery
Feb 4, 2022

Glioblastoma Trial in Boston (radiation, biological, drug)

Recruiting
  • Glioblastoma
  • Radiation Therapy
  • +3 more
  • Boston, Massachusetts
  • +1 more
May 31, 2022

Carcinoma, Squamous Cell, Head Neck Cancer Trial in Lexington (Cisplatin, XRT)

Recruiting
  • Carcinoma, Squamous Cell
  • Head and Neck Cancer
  • Lexington, Kentucky
    University of Kentucky
Nov 17, 2021

Diffuse Intrinsic Pontine Glioma, Anaplastic Astrocytoma, High Grade Glioma Trial run by the NCI (Lenalidomide, XRT, 54-59.4 Gy)

Completed
  • Diffuse Intrinsic Pontine Glioma
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 30, 2021